“IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?”, Mediterr J Hematol Infect Dis, vol. 13, no. 1, p. e2021062, Oct. 2021, doi: 10.4084/MJHID.2021.062.